BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 36171885)

  • 1. Comprehensive analysis about prognostic and immunological role of WTAP in pan-cancer.
    Lei J; Fan Y; Yan C; Jiamaliding Y; Tang Y; Zhou J; Huang M; Ju G; Wu J; Peng C
    Front Genet; 2022; 13():1007696. PubMed ID: 36171885
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic and Immunological Role of FUN14 Domain Containing 1 in Pan-Cancer: Friend or Foe?
    Yuan Q; Sun N; Zheng J; Wang Y; Yan X; Mai W; Liao Y; Chen X
    Front Oncol; 2019; 9():1502. PubMed ID: 31998650
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and immunological role of Fam20C in pan-cancer.
    Liu X; Zhan Y; Xu W; Liu X; Geng Y; Liu L; Da J; Wang J; Zhang X; Jin H; Liu Z; Guo S; Zhang B; Li Y
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33306121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
    Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC.
    Zhou L; Fu Z; Wang S; Jia J; Cheng Y; Zheng Y; Zhang N; Lu W; Yao Z
    Front Oncol; 2022; 12():875097. PubMed ID: 35586489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic Significance of
    Li Z; Cui Y; Duan Q; Zhang J; Shao D; Cao X; Gao Y; Wang S; Li J; Jones OD; Lei X; Wang L; Zhou X; Xu M; Ma J; Liu Y; Xu X
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
    Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
    Front Oncol; 2022; 12():809847. PubMed ID: 35957868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
    Ju Q; Li XM; Zhang H; Zhao YJ
    Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and Immunological Role of mRNA ac4C Regulator NAT10 in Pan-Cancer: New Territory for Cancer Research?
    Yang C; Wu T; Zhang J; Liu J; Zhao K; Sun W; Zhou X; Kong X; Shi J
    Front Oncol; 2021; 11():630417. PubMed ID: 34094911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-cancer analysis from multi-omics data reveals AAMP as an unfavourable prognostic marker.
    Wang Y; Liu T; Zhang K; Huang RH; Jiang L
    Eur J Med Res; 2023 Jul; 28(1):258. PubMed ID: 37501187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of RAB13 expression in pan-cancer based on multi-databases integrative analysis.
    Zhang XD; Liu ZY; Luo K; Wang XK; Wang MS; Huang S; Li RF
    Sci Rep; 2023 Oct; 13(1):16859. PubMed ID: 37803063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
    Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
    Front Immunol; 2022; 13():903461. PubMed ID: 35663977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel prognostic biomarker:
    Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
    Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD93 overexpresses in liver hepatocellular carcinoma and represents a potential immunotherapy target.
    Jiang Q; Kuai J; Jiang Z; Que W; Wang P; Huang W; Ding W; Zhong L
    Front Immunol; 2023; 14():1158360. PubMed ID: 37483608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.
    Feng H; Wei X; Pang L; Wu Y; Hu B; Ruan Y; Liu Z; Liu J; Wang T
    Front Mol Biosci; 2020; 7():189. PubMed ID: 33088807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Analyses of the Role of the Reader Protein of
    Shao XY; Dong J; Zhang H; Wu YS; Zheng L
    Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.